BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1176 related articles for article (PubMed ID: 26814169)

  • 1. Use of machine learning approaches for novel drug discovery.
    Lima AN; Philot EA; Trossini GH; Scott LP; Maltarollo VG; Honorio KM
    Expert Opin Drug Discov; 2016; 11(3):225-39. PubMed ID: 26814169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine learning in computational docking.
    Khamis MA; Gomaa W; Ahmed WF
    Artif Intell Med; 2015 Mar; 63(3):135-52. PubMed ID: 25724101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances with support vector machines for novel drug discovery.
    Maltarollo VG; Kronenberger T; Espinoza GZ; Oliveira PR; Honorio KM
    Expert Opin Drug Discov; 2019 Jan; 14(1):23-33. PubMed ID: 30488731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
    Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
    Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning approaches and their applications in drug discovery and design.
    Priya S; Tripathi G; Singh DB; Jain P; Kumar A
    Chem Biol Drug Des; 2022 Jul; 100(1):136-153. PubMed ID: 35426249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Task-Specific Scoring Functions for Predicting Ligand Binding Poses and Affinity and for Screening Enrichment.
    Ashtawy HM; Mahapatra NR
    J Chem Inf Model; 2018 Jan; 58(1):119-133. PubMed ID: 29190087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A renaissance of neural networks in drug discovery.
    Baskin II; Winkler D; Tetko IV
    Expert Opin Drug Discov; 2016 Aug; 11(8):785-95. PubMed ID: 27295548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the challenges of protein flexibility in drug design.
    Antunes DA; Devaurs D; Kavraki LE
    Expert Opin Drug Discov; 2015 Dec; 10(12):1301-13. PubMed ID: 26414598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial Intelligence, Big Data and Machine Learning Approaches in Precision Medicine & Drug Discovery.
    Nayarisseri A; Khandelwal R; Tanwar P; Madhavi M; Sharma D; Thakur G; Speck-Planche A; Singh SK
    Curr Drug Targets; 2021; 22(6):631-655. PubMed ID: 33397265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combined drug discovery strategy based on machine learning and molecular docking.
    Zhang Y; Wang Y; Zhou W; Fan Y; Zhao J; Zhu L; Lu S; Lu T; Chen Y; Liu H
    Chem Biol Drug Des; 2019 May; 93(5):685-699. PubMed ID: 30688405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current limits in virtual screening and property prediction.
    Hutter MC
    Future Med Chem; 2018 Jul; 10(13):1623-1635. PubMed ID: 29953247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep Learning in Structure-Based Drug Design.
    Anighoro A
    Methods Mol Biol; 2022; 2390():261-271. PubMed ID: 34731473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep Learning in Drug Discovery.
    Gawehn E; Hiss JA; Schneider G
    Mol Inform; 2016 Jan; 35(1):3-14. PubMed ID: 27491648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine-learning approaches in drug discovery: methods and applications.
    Lavecchia A
    Drug Discov Today; 2015 Mar; 20(3):318-31. PubMed ID: 25448759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macromolecular target prediction by self-organizing feature maps.
    Schneider G; Schneider P
    Expert Opin Drug Discov; 2017 Mar; 12(3):271-277. PubMed ID: 27997811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using machine learning to improve ensemble docking for drug discovery.
    Chandak T; Mayginnes JP; Mayes H; Wong CF
    Proteins; 2020 Oct; 88(10):1263-1270. PubMed ID: 32401384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative structure-activity relationship: promising advances in drug discovery platforms.
    Wang T; Wu MB; Lin JP; Yang LR
    Expert Opin Drug Discov; 2015 Dec; 10(12):1283-300. PubMed ID: 26358617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machine Learning Classification Models to Improve the Docking-based Screening: A Case of PI3K-Tankyrase Inhibitors.
    Berishvili VP; Voronkov AE; Radchenko EV; Palyulin VA
    Mol Inform; 2018 Nov; 37(11):e1800030. PubMed ID: 29901257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.
    Yang X; Wang Y; Byrne R; Schneider G; Yang S
    Chem Rev; 2019 Sep; 119(18):10520-10594. PubMed ID: 31294972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using reverse docking for target identification and its applications for drug discovery.
    Lee A; Lee K; Kim D
    Expert Opin Drug Discov; 2016 Jul; 11(7):707-15. PubMed ID: 27186904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.